CRP and myocardial infarction: Conventional biomarkers, such as cardiac troponins, creatine kinase-myocardial band (CK-MB), C-reactive protein (CRP), N-terminal pro-B-type natriuretic peptide (NT-proBNP), WBC count, and D-dimer, are routinely used to assess the severity and predict complications of MI [3].